Friday, February 21, 2025 | 04:15 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Aspira Pathlab & Diagnostics Share Price

Know More
BSENSE

₹65.89 1.29 (2.00%)

04:01 PM, 21-Feb-2025
Stock not traded

BSE : 540788

Sector : Health care

ISIN Code : INE500C01017

  • BSE
  • 1D
  • 5D
  • 1M
  • 6M
  • 1Y
  • 2Y
  • 5Y
  • MAX

Last Updated: 21-Feb-2025 | 10:31 AM IST

Market Cap (₹ Cr)

68

Traded Value (₹ Cr)

0.00

Volume (Shares)

389

Face Value (₹)

10

52-Week High (₹)

-

52-Week High Date

Invalid date

52-Week Low (₹)

-

52-Week Low Date

Invalid date

All Time High (₹)

-

All Time High Date

Invalid date

All Time Low (₹)

-

All Time Low Date

Invalid date

Aspira Pathlab & Diagnostics Ltd

Aspira Pathlab & Diagnostics Limited (ASDL) was incorporated in July 1973. ASDL is a leading pathology specialist with Pan-India presence. It offer pathology and diagnostic services to individual patients hospitals other healthcare providers and businesses. The Company with a wider presence in Maharashtra India enjoys a loyal customer base that reflects on its strength as a brand providing superior diagnostic testing and services.Presently Company is engaged into the business of running owning managing and administering Diagnostics Centers. Its principal activities consist of pathology investigation services radiology investigation services and other related healthcare services at Diagnostic...
Read More

Aspira Pathlab & Diagnostics Ltd - Key Fundamentals

PARAMETER VALUES
Market Cap (₹ Cr)

68

EPS - TTM (₹) [C]

0.82

P/E Ratio (X) [C]

80.35

Face Value (₹) 10
Latest Dividend (%)-
Latest Dividend Date -
Dividend Yield (%) -
Book Value Share (₹) [C]18.77
P/B Ratio (₹) [C]3.51

Funds Owning this Stock

Scheme Name Amount Invested (₹ Cr) No Of Shares Net Asset (%)

Research Reports

DateBrokerActionPrices(₹) Report
Data Not Found

Stock Strength

Today's Low/High (₹)

65.89

65.89

Week Low/High (₹)

62.10

65.89

Month Low/High (₹)

62.10

81.00

Share Price Returns

Period BSENSE SENSEXNIFTY
1 Week1.92%--0.83%-0.58%
1 Month-16.93%--0.70%-0.99%
3 Month2.47%--2.39%-2.37%
6 Month109.17%--6.91%-7.97%
1 Year90.71%-3.70%3.36%
3 Year-14.54%-30.56%32.48%

Company Info

Company Information

Managing Director & CEO : Pankaj Jashwant Shah

Independent Director : Mangala Radha Krishnan Prabhu

Chairman & Independent Directo : Haseeb Drabu

Executive Director : Nikunj Mange

Independent Director : Manas Mengar

Company Sec. & Compli. Officer : Krupali Shah

Registered Office: Flat No. 2 RD Shah Building, Shraddanand Road Ghatkopar(W),Mumbai,Maharashtra-400086 Ph: 91-22-71975756/5656

Email:info@aspiradiagnostics.com

URL:http://www.aspiradiagnostics.com

FAQs about Aspira Pathlab & Diagnostics Ltd

1. What's the Aspira Pathlab & Diagnostics Ltd share price today?
Aspira Pathlab & Diagnostics Ltd share price was Rs 65.89 at 04:01 PM IST on 21st Feb 2025. Aspira Pathlab & Diagnostics Ltd share price was up by 2.00% over the previous closing price of Rs 64.60. Aspira Pathlab & Diagnostics Ltd share price trend:

  • Last 1 Month: Aspira Pathlab & Diagnostics Ltd share price moved down by 16.93% on BSE
  • Last 3 Months: Aspira Pathlab & Diagnostics Ltd share price moved up by 2.47% on BSE
  • Last 12 Months: Aspira Pathlab & Diagnostics Ltd share price moved up by 90.71% on BSE
  • Last 3 Years: Aspira Pathlab & Diagnostics Ltd price moved down by 14.54% on BSE


2. How can I quickly analyse the performance of the Aspira Pathlab & Diagnostics Ltd stock?
The performance of the Aspira Pathlab & Diagnostics Ltd stock can be quickly analysed on the following metrics:

  • The stock's PE is 80.35
  • Price to book value ratio is 3.51
  • Dividend yield of 0.00
  • The EPS (trailing 12 months) of the Aspira Pathlab & Diagnostics Ltd stock is Rs 0.82


3. What is the market cap of Aspira Pathlab & Diagnostics Ltd?
Aspira Pathlab & Diagnostics Ltd has a market capitalisation of Rs 68 crore.


4. What is Aspira Pathlab & Diagnostics Ltd's 52-week high/low share price?
The Aspira Pathlab & Diagnostics Ltd’s 52-week high share price is Rs - and 52-week low share price is Rs -.


5. Is the Aspira Pathlab & Diagnostics Ltd profitable?
On a consolidated basis, Aspira Pathlab & Diagnostics Ltd reported a profit of Rs 0.38 crore on a total income of Rs 5.50 crore for the quarter ended 2024. For the year ended Dec 2024, Aspira Pathlab & Diagnostics Ltd had posted a profit of Rs 0.31 crore on a total income of Rs 5.50 crore.


6. Which are Aspira Pathlab & Diagnostics Ltd’s peers in the Health care sector?
Aspira Pathlab & Diagnostics Ltd’s top 5 peers in the Health care sector are Jeevan Scienti., Sunil Healthcare, Shanmuga Hos., Aspira Pathlab, Bandaram Pharma, N G Industries, Deccan Healthcar.


7. Who owns how much in Aspira Pathlab & Diagnostics Ltd?
Key changes to the Aspira Pathlab & Diagnostics Ltd shareholding are as follows:

  • Promoter holding in Aspira Pathlab & Diagnostics Ltd has gone down to 18.55 per cent as of Dec 2024 from 18.72 per cent as of Mar 2024.
  • Indian Public holding in Aspira Pathlab & Diagnostics Ltd has gone up to 60.28 per cent as of Dec 2024 from 55.71 per cent as of Mar 2024.
  • Non Institutional Investors holding in Aspira Pathlab & Diagnostics Ltd has gone down to 21.17 per cent as of Dec 2024 from 25.57 per cent as of Mar 2024.
  • Financial Institutions holding in Aspira Pathlab & Diagnostics Ltd has gone up to 0.00 per cent as of Dec 2024 from 0.00 per cent as of Mar 2024.
  • Foreign Institutional Investors holding in Aspira Pathlab & Diagnostics Ltd has gone up to 0.00 per cent as of Dec 2024 from 0.00 per cent as of Mar 2024.
  • Insurance Companies holding in Aspira Pathlab & Diagnostics Ltd has gone up to 0.00 per cent as of Dec 2024 from 0.00 per cent as of Mar 2024.
  • Mutual Funds Uti holding in Aspira Pathlab & Diagnostics Ltd has gone up to 0.00 per cent as of Dec 2024 from 0.00 per cent as of Mar 2024.
  • Other Institutional Investors holding in Aspira Pathlab & Diagnostics Ltd has gone up to 0.00 per cent as of Dec 2024 from 0.00 per cent as of Mar 2024.
  • Custodians holding in Aspira Pathlab & Diagnostics Ltd has gone up to 0.00 per cent as of Dec 2024 from 0.00 per cent as of Mar 2024.